Phacilitate Leaders Forum

Speakers

Loading
Anna Mondino

Anna Mondino

Head of Research Unit, Hospital San Raffaele

Anna Mondino obtained a Master degree in Biological Sciences and a PhD degree in Oncology from the University of Torino. As a student she trained in Cell Biology and Oncology at the University of Torino (1986-1990) and at the New York Medical School (1991-1992), and then in Immunology, as a postdoctoral fellow at the University of Minnesota (1993-1998). Since 1999 she is the Head of the Lymphocyte Activation Unit within the Division of Immunology, Transplantation and Infectious Diseases at IRCCS Ospedale San Raffaele in Milan, Italy. Her goal is to perform cutting edge biomedical research on topics relevant to human diseases and provide advanced training to national and international research fellows. Her research interests are focused on the cellular and molecular events critical to T-cell mediated immunity for the clinical implementation of T cell therapy against solid tumors. She is the author of 73 peer-reviewed publications. She trained more than 35 fellows, including undergraduate and graduate students and postdoctoral fellows.

Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
    Celyad
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd